Home » Regions » Global News » The CenterWatch Monthly Industry Close-Up, September 2017

The CenterWatch Monthly Industry Close-Up, September 2017

Friday, September 1, 2017

In 2017, 13% of cancer diagnosed in adults will be rare cancers. Of those, prostate cancer represents 9.6% in the U.S. Prostate cancer is the second most common cancer and the second leading cause of cancer-related death in men in the U.S. According to the National Center for Health Statistics, approximately $11.9 billion is spent each year in the U.S. on prostate cancer treatment.

 

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Related Posts